publication date: Dec. 19, 2010

In this issue: 

White House preparing to nominate Andrew von Eschenbach as FDA commissioner, sources said.

FDA approves Erbitux for head & neck cancer.

Nancy Davidson elected ASCO president.

NCI releases list of cancer center core grant funding for FY 2005; Univ. of New Mexico is the newest NCI-designated center.

At AAAS meeting, David Baltimore comments on Bush administration science policy.

Download (PDF 818KB)

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.